National Australia Bank FY Profit Rises

National Australia Bank Ltd. (NAUBF.PK,NABZY.PK, NAB.AX) reported that its net profit attributable to owners of the company for fiscal year 2022 rose to A$6.89 billion or 205.6 cents per share from A$6.36 billion or 185.2 cents per share in the prior year.

Cash earnings were A$7.10 billion or 211.7 cents per share up from A$6.56 billion or 191.0 cents per share in the previous year.

The company stated that cash earnings rose 8.3% and all businesses contributed to underlying profit growth of 11.5%. The outcome reflects continued execution of strategy including targeted volume growth and a disciplined approach to managing costs while investing for growth. After 11 years of interest rate reductions, earnings have also benefitted in fiscal year 2022 from the rising interest rate environment.

Net interest income for the year grew to A$14.85 billion from A$13.80 billion last year. Other operating income was A$3.44 billion up from A$3.01 billion in the prior year.

Revenue increased 8.9%. Excluding the impact of the Citi consumer business, revenue rose 7.8% mainly reflecting higher volumes and slightly higher margins excluding Markets & Treasury (M&T).

The company said it is well positioned for a changing Australian home lending market with slowing credit demand combined with heightened refinancing activity and competitive pressures expected.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Pfizer Inc. reported Tuesday higher earnings in its fourth quarter, above market estimates, and an all-time high revenues in its fiscal 2022. Meanwhile, the company projects sharply lower adjusted earnings and revenues in its fiscal 2023, below Wall Street estimates, reflecting projected decline for COVID-19 products. In pre-market activity on the NYSE, Pfizer shares were losing around Oil major Exxon Mobil Corp. (XOM) reported Tuesday that fourth-quarter net income was $12.75 billion or $3.09 per share, up from $8.87 million or $2.08 per share in the prior-year quarter. Excluding special items, adjusted earnings were $3.40 per share, compared to $2.05 per share in the prior-year... La Mirada, California-based Daiso California LLC is recalling certain Matsunaga Mini Shiruko Sand Biscuits citing undeclared soy, an allergen, the U.S. Food and Drug Administration said. The recall incolves Matsunaga Mini Shiruko Sand Biscuits with sku 4902773016966, packaged in four pink and cream bags chained together. Each individual serving is 25g for an entire product weight of 100g.
Follow RTT